2,469 institutions hold shares in CVS Health Corporation (CVS), with 2.74M shares held by insiders accounting for 0.21% while institutional investors hold 78.65% of the company’s shares. The shares outstanding are 1.31B, and float is at 1.31B with Short Float at 1.32%. Institutions hold 78.49% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 105.38 million shares valued at $7.2 billion. The investor’s holdings represent 8.04% of the CVS Shares outstanding. As of Dec 30, 2020, the second largest holder is Blackrock Inc. with 92.48 million shares valued at $6.32 billion to account for 7.05% of the shares outstanding. The other top investors are State Street Corporation which holds 54.46 million shares representing 4.15% and valued at over $3.72 billion, while Capital World Investors holds 2.64% of the shares totaling 34.66 million with a market value of $2.37 billion.
CVS Health Corporation (NYSE: CVS) is 9.06% higher on its value in year-to-date trading and has touched a low of $55.36 and a high of $77.23 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CVS stock was last observed hovering at around $74.62 in the last trading session, with the day’s loss setting it -0.13% off its average median price target of $86.00 for the next 12 months. It is also 26.97% off the consensus price target high of $102.00 offered by 27 analysts, but current levels are -3.46% lower than the price target low of $72.00 for the same period.
Currently trading at $74.49, the stock is 0.52% and 2.66% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.13 million and changing -0.17% at the moment leaves the stock 11.80% off its SMA200. CVS registered 32.50% gain for a year compared to 6-month gain of 26.36%. The firm has a 50-day simple moving average (SMA 50) of $72.25 and a 200-day simple moving average (SMA200) of $68.16.
The stock witnessed a 3.85% loss in the last 1 month and extending the period to 3 months gives it a 5.72%, and is -2.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.40% over the week and 2.00% over the month.
CVS Health Corporation (CVS) has around 300000 employees, a market worth around $98.91B and $268.71B in sales. Current P/E ratio is 13.61 and Fwd P/E is 9.18. Profit margin for the company is 2.70%. Distance from 52-week low is 34.56% and -3.55% from its 52-week high. The company has generated returns on investments over the last 12 months (7.40%).
CVS Health Corporation (CVS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for CVS Health Corporation (CVS) is a “Overweight”. 27 analysts offering their recommendations for the stock have an average rating of 2.10, where 7 rate it as a Hold and 3 think it is a “Overweight”. 17 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
CVS Health Corporation is expected to release its quarterly report on 08/04/2021 and quarterly earnings per share for the current quarter are estimated at $1.72 with sales reaching $68.35B over the same period.The EPS is expected to grow by 7.60% this year, but quarterly earnings will post 4.20% year-over-year. Quarterly sales are estimated to grow 2.40% in year-over-year returns.
CVS Health Corporation (CVS) Insider Activity
A total of 66 insider transactions have happened at CVS Health Corporation (CVS) in the last six months, with sales accounting for 34 and purchases happening 32 times. The most recent transaction is an insider sale by Moriarty Thomas M, the company’s EVP & General Counsel. SEC filings show that Moriarty Thomas M sold 62,943 shares of the company’s common stock on Mar 29 at a price of $76.15 per share for a total of $4.79 million. Following the sale, the insider now owns 0.0 shares.
CVS Health Corporation disclosed in a document filed with the SEC on Mar 26 that Roberts Jonathan C (EVP & Chief Operating Officer) sold a total of 73,433 shares of the company’s common stock. The trade occurred on Mar 26 and was made at $74.49 per share for $5.47 million. Following the transaction, the insider now directly holds 664.0 shares of the CVS stock.
Still, SEC filings show that on Mar 26, MERLO LARRY J (Director) disposed off 270,650 shares at an average price of $74.73 for $20.23 million. The insider now directly holds 524,026 shares of CVS Health Corporation (CVS).
CVS Health Corporation (CVS): Who are the competitors?
The company’s main competitors (and peers) include Walgreens Boots Alliance Inc. (WBA) that is trading 30.38% up over the past 12 months and PetMed Express Inc. (PETS) that is 8.59% higher over the same period. Short interest in the company’s stock has fallen -1.71% from the last report on Mar 14, 2021 to stand at a total of 17.29 million short shares sold with a short interest ratio of 2.18.